Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and future
Open accessThe DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
Immunogenic cell death (ICD) is a unique mode of cell death that could trigger tumour-specific immune response. Metal-based drugs which have emerged as promising agents within the lexicon of possible ICD inducers will be the topic of this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Platinum-based drugs have demonstrated potential to induce an anti-cancer immune response by promoting the recruitment and activation of immune cells [95, 96], thereby enhancing the efficacy of immunotherapies.”
From Advances in platinum-based cancer therapy: overcoming platinum resistance through rational combinatorial strategies (2025) · cites this paper as [95]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Sabbatini, M., Zanellato, I., Ravera, M., Gabano, E., Perin, E., Rangone, B., & Osella, D. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01860 · Cited by 63
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay-Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,256
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
Immunogenic cell death and DAMPs in cancer therapy
Krysko, D. V., Garg, A. D., Kaczmarek, A., Krysko, O., Agostinis, P., & Vandenabeele, P. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3380 · Cited by 3,223
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Immunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056
Johnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00597 · Cited by 2,485
Research works printed but not linked: 3
- Zhu, 2021, Small, 17, 1
- Rébé, 2020, Biomolecules, 10, 1
- Wernitznig, 2019, Metallomics, 11, 1044, 10.1039/c9mt00051h · DOI
Cited by
Lee, L. C.-C., & Lo, K. K.-W. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c03437 · Cited by 279
Cheng, H., Cao, X., Zhang, S., Zhang, K., Cheng, Y., Wang, J., Zhao, J., Zhou, L., Liang, X., & Yoon, J. (2023) · Advanced Materials · doi:10.1002/adma.202207546 · Cited by 260
Bioactive inorganic nanomaterials for cancer theranostics
Pei, Z., Lei, H., & Cheng, L. (2023) · Chemical Society Reviews · doi:10.1039/d2cs00352j · Cited by 255
Immunogenic Cell Death Inducing Metal Complexes for Cancer Therapy
Zhang, L., Montesdeoca, N., Karges, J., & Xiao, H. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202300662 · Cited by 215
Metal-Based Photosensitizers as Inducers of Regulated Cell Death Mechanisms
Zhang, Y., Doan, B.-T., & Gasser, G. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00161 · Cited by 213
Organometallic anti-tumor agents: targeting from biomolecules to dynamic bioprocesses
Peng, K., Zheng, Y., Xia, W., & Mao, Z.-W. (2023) · Chemical Society Reviews · doi:10.1039/d2cs00757f · Cited by 188
Connecting Calcium-Based Nanomaterials and Cancer: From Diagnosis to Therapy
Bai, S., Lan, Y., Fu, S., Cheng, H., Lu, Z., & Liu, G. (2022) · Nano-Micro Letters · doi:10.1007/s40820-022-00894-6 · Cited by 175
Cheng, G., Kwong, C. H. T., Wang, Q., Kam, H., Xie, B., Lee, S. M., Chen, G., & Wang, R. (2023) · ACS Nano · doi:10.1021/acsnano.3c00041 · Cited by 157
Next Generation Gold Drugs and Probes: Chemistry and Biomedical Applications
Mertens, R. T., Gukathasan, S., Arojojoye, A. S., Olelewe, C., & Awuah, S. G. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00649 · Cited by 151
Tu, L., Li, C., Ding, Q., Sharma, A. K., Li, M., Li, J., Kim, J. S., & Sun, Y. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.3c13224 · Cited by 132
Self-citationWang, L., Karges, J., Wei, F., Xie, L., Chen, Z., Gasser, G., Ji, L., & Chao, H. (2023) · Chemical Science · doi:10.1039/d2sc06675k · Cited by 119
Zhou, H., Tang, D., Yu, Y., Zhang, L., Wang, B., Karges, J., & Xiao, H. (2023) · Nature Communications · doi:10.1038/s41467-023-40826-5 · Cited by 124
Materials engineering strategies for cancer vaccine adjuvant development
Zhang, X., Yang, B., Ni, Q., & Chen, X. S. (2023) · Chemical Society Reviews · doi:10.1039/d2cs00647b · Cited by 109
Li, Y., Wu, Y., Fang, Z., Zhang, Y., Haitao, D., Ren, L., Zhang, L., Gong, Q., Gu, Z., & Luo, K. (2023) · Advanced Materials · doi:10.1002/adma.202307263 · Cited by 117
Metal‐based smart nanosystems in cancer immunotherapy
Luo, Y., He, X., Du, Q., Xu, L., Xu, J., Wang, J., Zhang, W., Zhong, Y., Guo, D., Liu, Y., et al. (2024) · Exploration · doi:10.1002/exp.20230134 · Cited by 112
Xiong, X., Huang, K.-B., Wang, Y., Cao, B., Luo, Y., Chen, H. W., Yang, Y. H., Long, Y., Liu, M., Chan, A. S. C., et al. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c02435 · Cited by 97
Oxaliplatin and its derivatives – An overview
O'Dowd, P., Sutcliffe, D. F., & Griffith, D. M. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215439 · Cited by 102
Li, H., Luo, Q., Zhang, H., Ma, X., Gu, Z., Gong, Q., & Luo, K. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00437b · Cited by 97
Copper‐Bacteriochlorin Nanosheet as a Specific Pyroptosis Inducer for Robust Tumor Immunotherapy
Zhang, Y., Jia, Q., Li, J., Wang, J., Liang, K., Xue, X., Chen, T., Kong, L., Ren, H., Liu, W., et al. (2023) · Advanced Materials · doi:10.1002/adma.202305073 · Cited by 77
Yang, Z., Zhao, Z., Cheng, H., Shen, Y., Xie, A., & Zhu, M. (2023) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2023.03.065 · Cited by 76
Wu, X., Liang, J., Shu, J., Li, Z., Yin, T., Zhang, X., & Chao, H. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c00843 · Cited by 84
Lei, H., Li, Q., Li, G., Wang, T., Lv, X., Pei, Z., Gao, X., Yang, N., Gong, F., Yang, Y., et al. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.07.026 · Cited by 77
Yang, C., Ming, H., Li, B., Liu, S., Chen, L., Zhang, T., Gao, Y., He, T., Huang, C., & Du, Z. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.10.043 · Cited by 76
Li, C., Tu, L., Xu, Y., Li, M., Du, J., Stang, P. J., Sun, Y., & Sun, Y. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202406392 · Cited by 77
Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds
Amiri, M., Molavi, O., Sabetkam, S., Jafari, S., & Montazersaheb, S. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03058-7 · Cited by 73
“Several non-platinum metal-based agents such as ruthenium-based compounds can be used as an alternative to platinum-anticancer agents [58].”
BackgroundYuan, L., Wang, S., Li, M., Liu, R., Zhu, M.-F., Yang, L.-M., Wang, F.-Y., Huang, K.-B., & Liang, H. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.06.017 · Cited by 70
“A key endogenous signal that induces the immunogenicity of tumor cells is the extracellular secretion of high mobility group protein 1 (HMGB1) from the nucleus 60 .”
Zhu, L., Song, G., Zhang, W., Wu, Y., Chen, Y., Song, J., Wang, D., Li, G., Tang, B. Z., & Li, Y. (2025) · Nature Communications · doi:10.1038/s41467-025-57533-y · Cited by 63
“responses 11,12 .”
Meng, M., Wu, J., Feng, Y., Lin, L., Chen, J., Pang, X., Li, Y., Hao, K., Tian, H., & Chen, X. (2024) · Advanced Materials · doi:10.1002/adma.202314309 · Cited by 66
Cytotoxicity and mechanism of action of metal complexes: An overview
Abdolmaleki, S., Khaksar, S., Aliabadi, A., Panjehpour, A., Motieiyan, E., Marabello, D., Faraji, M. H., & Beihaghi, M. (2023) · Toxicology · doi:10.1016/j.tox.2023.153516 · Cited by 70
Mn( iii )-mediated carbon-centered radicals generate an enhanced immunotherapeutic effect
Li, J., Hu, B., Chen, Z., Li, J., Jin, W., Wang, Y., Wan, Y., Lv, Y., Pei, Y., Liu, H., et al. (2023) · Chemical Science · doi:10.1039/d3sc03635a · Cited by 59
Pei, Z., Lei, H., Wu, J., Tang, W., Wei, K., Wang, L., Gong, F., Yang, N., Liu, L., Yang, Y., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c04767 · Cited by 58
Advanced strategies for combinational immunotherapy of cancer based on polymeric nanomedicines
You, K., Wang, Q., Osman, M. S., Kim, D., Li, Q., Feng, C., Wang, L., & Yang, K. (2024) · BMEMat · doi:10.1002/bmm2.12067 · Cited by 63
Manipulating calcium homeostasis with nanoplatforms for enhanced cancer therapy
Feng, Y., Wang, J., Cao, J.-M., Cao, F., & Chen, X. S. (2023) · Exploration · doi:10.1002/exp.20230019 · Cited by 60
Li, Y., Shen, X., Haitao, D., Zhang, Y., Pan, D., Su, L., Wu, Y., Fang, Z., Zhou, J., Gong, Q., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.03.010 · Cited by 62
“Consequently, unsatisfied ICD is triggered and weak/no immune response is provoked, leading to the failure of cancer treatment 14 .”
Nano‐Engineered Magnesium Implants for Magnetothermal Enhanced Pyroptosis to Boost Immunotherapy
Han, X., Sun, S., Yang, N., Han, Z., Pei, Z., Yu, Q., Nie, J., Wang, L., Liu, A., Meng, X., et al. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202405836 · Cited by 53
Sarkar, A., Novohradský, V., Maji, M., Babu, T., Marková, L., Kostrhunová, H., Kašpárková, J., Gandin, V., Brabec, V., & Gibson, D. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202310774 · Cited by 50
Han, Y., Tian, X., Zhai, J., & Zhang, Z. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1363121 · Cited by 59
“Of note, most current known inducers, such as chemotherapy and RT, are type I (Sen et al., 2022) and their immune ef fi cacy needs to be enhanced by new biomaterials or combination therapies.”
BackgroundRecent Progress in Photodynamic Immunotherapy with Metal‐Based Photosensitizers
Xiong, K., Wei, F., Chen, Y., Ji, L., & Chao, H. (2022) · Small Methods · doi:10.1002/smtd.202201403 · Cited by 52
Yuan, L., Wang, F.-Y., Levine, M. S., Shi, H.-R., Wang, Y., Xiong, X., Yang, L.-M., Shi, Y., Zou, T., Sessler, J. L., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c00255 · Cited by 50
Self-citationLiu, J., Song, Y., Wang, Y., Han, M., Wang, C., & Yan, F. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c09978 · Cited by 44
Intracellular metal ion-based chemistry for programmed cell death
You, Y., Guo, Z., Wolter, T., & Hu, Q. (2025) · Chemical Society Reviews · doi:10.1039/d4cs00930d · Cited by 51
Emerging platinum(IV) prodrug nanotherapeutics: A new epoch for platinum-based cancer therapy
Zheng, S., Li, G., Shi, J., Liu, X., Li, M., He, Z., Tian, C., & Kamei, K. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.08.035 · Cited by 46
Ghorbanpour, M., Shayanfar, A., & Soltani, B. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215459 · Cited by 45
Zhou, Z., Mai, Y., Zhang, G., Wang, Y., Sun, P., Jing, Z., Li, Z., Xu, Y., Han, B. R., & Liu, J. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217079 · Cited by 46
Jiang, F., Liu, Y., Xue, Y., Cheng, P., Wang, J., Lian, J., & Gong, W. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109728 · Cited by 45
“IFN-γ plays a vital role in activating T cells (mainly Th1 and CTL), promoting NK cell activity, presenting antigens, and activating macrophage lysosomes [111 – 113].”
Hu, R., Qin, J., Feng, W., Song, X., Huang, H., Dai, C., Zhang, B., & Chen, Y. (2025) · Science Advances · doi:10.1126/sciadv.adu3919 · Cited by 43
“The notable impact of Mn 2 + on cancer immunotherapy has sparked growing interest in the concept of “metals in medicine” ( 35 ).”
Wen, H., Zhong, Y.-X., Yin, Y., Qin, K.-M., Yang, L., Li, D., Yu, W., Yang, C., Deng, Z., & Hong, K. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.70975 · Cited by 44
“However, only a few small molecules have shown ICD effects [48].”
BackgroundDai, X., Li, X., Du, Y., Han, M., Wang, Z., Wang, Y., Yan, F., & Liu, Y. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.141426 · Cited by 40
Metal-based immunogenic cell death inducers for cancer immunotherapy
Zou, J. X., Chang, M. R., Kuznetsov, N. A., Kee, J. X., Babak, M. V., & Ang, W. H. (2025) · Chemical Science · doi:10.1039/d4sc08495k · Cited by 47
Rahimi, A. R., Baghernejadan, Z., Hazrati, A., Malekpour, K., Samimi, L. N., Najafi, A., Falak, R., & Khorramdelazad, H. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118014 · Cited by 43
Levina, A., Crans, D. C., & Lay, P. A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040790 · Cited by 39
Xie, L., Ding, Y., Zhang, X., Zhang, Z., Zeng, S., Wang, L., Yang, Z., Liu, Q., & Hu, Z. (2023) · Small Methods · doi:10.1002/smtd.202201416 · Cited by 38
Zhou, J., Shen, Q., Hong, X.-J., Zhang, W.-Y., Su, Q., Li, W.-G., Cheng, B., Tan, C., & Wu, T. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.145516 · Cited by 38
Development of Platinum Complexes for Tumor Chemoimmunotherapy
Jin, S., Guo, Y., & Wang, X. (2024) · Chemistry - A European Journal · doi:10.1002/chem.202302948 · Cited by 39
Recent advances in the development of metallodrugs for cancer chemoimmunotherapy
Wei, F., Liang, J., Shen, X., Pan, Y., He, Y., & Chao, H. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.216319 · Cited by 39
Yusoh, N. A., Ahmad, H., Vallis, K. A., & Gill, M. R. (2025) · Medical Oncology · doi:10.1007/s12032-025-02812-3 · Cited by 40
“Platinum-based drugs have demonstrated potential to induce an anti-cancer immune response by promoting the recruitment and activation of immune cells [95, 96], thereby enhancing the efficacy of immunotherapies.”
Zhuo, X., Liu, Z., Aishajiang, R., Wang, T., & Yu, D. N. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092293 · Cited by 38
The emergence of cancer sono-immunotherapy
Yang, Y., Cheng, Y., & Cheng, L. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.06.001 · Cited by 41
Guo, Y., Pan, J., Wang, J., Zhang, H., Yang, W., Chen, F., Yin, B., Cai, X., Tao, W., Lammers, T., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c00124 · Cited by 36
Application of photodynamic activation of prodrugs combined with phototherapy in tumor treatment
Du, Y., Zhao, J., Li, S., & Yuan, H. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02404-9 · Cited by 45
“Chemotherapy and phototherapy, etc. can trigger ICD [139–141].”
Pei, Z., Li, L., Yang, N., Sun, S., Jiang, N., & Cheng, L. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.215969 · Cited by 37
Manisha, Kumar, A., Abid, M., Ahmedi, S., Manzoor, N., Alam, R., & Jain, P. (2025) · Journal of Dispersion Science and Technology · doi:10.1080/01932691.2025.2461124 · Cited by 34
Romani, D., Marchetti, F., Nicola, C. D., Cuccioloni, M., Gong, C., Eleuteri, A. M., Galindo, A., Fadaei‐Tirani, F., Nabissi, M., & Pettinari, R. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01374 · Cited by 33
Li, X., Wang, M., Zeng, L., Li, G., Zhao, R., Liu, F.-D., Li, Y., Yan, Y., Liu, Q., Li, Z., et al. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202402028 · Cited by 38
Wang, P., Yu, L., Shen, Q., Dao, J., Zhang, D., Li, Z., Zhang, X., Hu, Q., & Tan, C. (2025) · Advanced Materials · doi:10.1002/adma.202506349 · Cited by 50
Wei, F., Karges, J., Gao, S., Wang, L., Zhang, X., Shen, X., Ji, L., & Chao, H. (2023) · Nano Today · doi:10.1016/j.nantod.2023.102066 · Cited by 33
Wang, L., Zhou, H., Chen, Q., Lin, Z., Jiang, C., Chen, X., Chen, M., Liu, L., Shao, L., Liu, X., et al. (2023) · Advanced Science · doi:10.1002/advs.202307858 · Cited by 34
Chang, M. R., Matnurov, E. M., Wu, C., Arakelyan, J., Choe, H.-J., Kushnarev, V. A., Yap, J. Y., Soo, X. X., Chow, M. J., Berger, W., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.4c17966 · Cited by 35
Reversible Chemistry for Cancer Therapy and Diagnosis
Xu, H., Hong, H., Kim, C., Lee, Y., Li, Y., Zhang, Y. S., Makvandi, P., Song, G., Zhang, H., Kang, H., et al. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.5c00549 · Cited by 34
Yang, Y., Du, L.-Q., Huang, Y., Liang, C.-J., Qin, Q., & Liang, H. (2023) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2023.112152 · Cited by 31
Deng, Y., Tang, S., Wang, M., Ren, X., Li, X., Zeng, L.-Z., Ren, D.-N., Wang, M., Xiao, W., Cai, Z., et al. (2023) · Inorganic Chemistry Frontiers · doi:10.1039/d3qi00903c · Cited by 30
Rising Interest in the Development of Metal Complexes in Cancer Immunotherapy
Li, Z., Shen, Q., Mao, Z., & Tan, C. (2022) · Chemistry - An Asian Journal · doi:10.1002/asia.202200270 · Cited by 29
Controversial Role of Transferrin in the Transport of Ruthenium Anticancer Drugs
Levina, A., Chetcuti, A. R. M., & Lay, P. A. (2022) · Biomolecules · doi:10.3390/biom12091319 · Cited by 32
Zhao, P., Wang, H., Zhao, H., Yin, C., Xing, Y., Wang, J., Chi, L., Ye, L., & Gu, W. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.150524 · Cited by 32
Wei, F., Ke, L., Gao, S., Karges, J., Wang, J., Chen, Y., Ji, L., & Chao, H. (2023) · Chemical Science · doi:10.1039/d3sc02264a · Cited by 29
Majumdar, D., Philip, J. E., Roy, S., Gassoumi, B., & Ghalla, H. (2025) · BMC Chemistry · doi:10.1186/s13065-025-01570-7 · Cited by 32
“As a result, inorganic chemists focus on investigating SB complexes as alternatives for biomedical compounds [5–7].”
Ma, G., Du, S., Li, X., Yu, D., Chao, M., Tang, R., Jing, C., Li, J., Liu, Y., Su, T., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123794 · Cited by 31
Zhao, J., Zhang, L. L., Li, P., Liu, S., Yu, S., Chen, Z., Zhu, M., Xie, S., Ling, D., & Li, F. (2023) · Advanced Science · doi:10.1002/advs.202307389 · Cited by 31
Rong, Y., Fan, Z., Yu, Z., Li, W., Shen, H., Huang, H., Hao, X., Zhao, Z., & Wang, J. (2023) · Inorganic Chemistry Frontiers · doi:10.1039/d3qi00841j · Cited by 25
Man, X., Sun, Z., Li, S., Xu, G., Li, W., Zhang, Z., Liang, H., & Yang, F. (2024) · Rare Metals · doi:10.1007/s12598-024-02759-w · Cited by 24
“…equally to this work. nodes, where they present the tumor antigens and induce T cell activation [16], which subsequently evokes the anti-tumor immune response of the host and improves the immunosuppressive microenvironment of solid tumors, thereby significantly facilitating cancer treatment [17].”
Liu, B., Liang, B., Cao, W.-D., Su, X., Cao, Q., & Mao, Z. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202410586 · Cited by 27
Zhao, Z., Wang, X., Wang, J., Li, Y., Lin, W., Lu, K., Chen, J., Xia, W. T., & Mao, Z. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00557 · Cited by 25
Marco, A., Ashoo, P., Hernández‐García, S., Martínez‐Rodríguez, P., Cutillas, N., Vollrath, A. M., Jordan, D. N., Janiak, C., Gandía‐Herrero, F., & Ruiz, J. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01869 · Cited by 25
Metal-Based Drugs in Cancer Therapy
Nath, S., Datta, A., Das, A., & Adhikari, S. (2024) · International Journal of experimental research and review · doi:10.52756/ijerr.2024.v37spl.014 · Cited by 28
“Over the years, this complex disease has grown exponentially, leading to remarkable advances in cancer diagnosis and treatment (Bhattacharjee and Mukherjee, 2016; Das et al., 2021; Boga and Bisgin, 2022; Sen et al., 2022; Kesavan et al., 2023; Kulkarni et al., 2023).”
BackgroundRen, D., Xiong, S., Ren, Y., Yang, X., Zhao, X., Jin, J., Xu, M., Liang, T., Guo, L., & Weng, L. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.04.054 · Cited by 23
“ICD is a key process in transforming cancer cells into tumor vaccines and mediating the immune clearance of cancer cells through the interface interaction between DAMPs and DCs. ICD is a unique and highly beneficial target for cancer therapy [16,41,90].”
BackgroundLiu, Y., Xie, J., Zhao, X., Zhang, Y., Zhong, Z., & Deng, C. (2022) · Biomaterials Science · doi:10.1039/d2bm01181f · Cited by 23
Tang, S., Li, Q., Wang, M., Yang, R., Zeng, L., Li, X., Wang, R.-D., Zhang, H., Ren, X., Zhang, D., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202301227 · Cited by 23
Organoruthenium-bipyridyl complexes – A platform for diverse chemistry and applications
Pandya, C., & Sivaramakrishna, A. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.215655 · Cited by 27
Yang, J., Wang, F., Huang, S., Feng, T., Xiong, K., Chen, Y., & Chao, H. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202505689 · Cited by 21
Levine, M. S., Sen, S., Maier, E. Y., da Mota, M. M. M., Won, M., Li, J., Arambula, J. F., Lynch, V. M., Kim, J. S., DePinho, R. A., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c03455 · Cited by 23
Self-citationChen, Y., Ke, Z., Yuan, L., Liang, M., & Zhang, S. (2023) · Dalton Transactions · doi:10.1039/d3dt01750h · Cited by 22
Cyclometalated iridium(III) complexes induce immunogenic cell death in HepG2 cells via paraptosis
Liao, J., Zhang, Y., Huang, M.-Y., Liang, Z., Gong, Y., Liu, B., Li, Y., Chen, J., Wu, W., Huang, Z., et al. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106837 · Cited by 24
Li, J., Yi, H., Fu, Y., Zhuang, J., Zhan, Z., Guo, L., Zheng, J., Yu, X., & Zhang, D. (2024) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2024.10.156 · Cited by 22
Zeng, L.-Z., Li, X., Deng, Y., Zhao, R., Song, R., Yan, Y., Wang, M., Wang, X., Ren, X., & Gao, F. (2025) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.4c04282 · Cited by 21
Immunogenic cell death-inducing metal complexes: From the benchtop to the clinic
Sen, S., Karoscik, K., Maier, E. Y., & Arambula, J. F. (2023) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2023.102277 · Cited by 23
Self-citationSovari, S. N., Kolly, I., Schindler, K., Djurić, A., Srdić‐Rajić, T., Crochet, A., Pavic, A., & Zobi, F. (2023) · Dalton Transactions · doi:10.1039/d2dt04041g · Cited by 21
Bioinspired Tumor Calcification‐Guided Early Diagnosis and Eradication of Hepatocellular Carcinoma
Bai, S., Chen, H., Fu, S., Liu, L., Gao, X., Li, S., Chen, Y., Lan, Y., Xia, Y., Dai, Q., et al. (2024) · Advanced Materials · doi:10.1002/adma.202310818 · Cited by 22
Li, W., Li, S., Man, X., Xu, G., Zhang, Z., Zhang, Y., Liang, H., & Yang, F. (2024) · Rare Metals · doi:10.1007/s12598-024-02871-x · Cited by 26
“…agents that induce ICD are promising for improving treatment using immune Supplementary Information The online version contains supplementary material available at https://doi.org/10.1007/s12598-024-02871-x. checkpoint inhibitors and may become the mainstay of cancer treatment in the future [7, 8].”
InfluentialHan, M. H., Zhou, S., Liao, Z., Chen, Z., Yi, X., Wu, C., Zhang, D., He, Y., Leong, K. W., & Zhong, Y. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122934 · Cited by 20
Bioactive metallic nanoparticles for synergistic cancer immunotherapy
Wang, L., Lin, D., Li, M., Yu, J., Yang, Y., Wang, H., Chu, H., Ye, J., & Liu, Y. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.02.022 · Cited by 24
“Expression of DAMPs effectively stimulates the activation and recruitment of a wide range of immune cells.”
Influential
Metadata
- Authors
- Sen, S., Won, M., Levine, M. S., Noh, Y., Sedgwick, A. C., Kim, J. S., Sessler, J. L., & Arambula, J. F.
- Affiliations
- The University of Texas at Austin (US)
- Korea University (KR)
- Corresponding author
- Kim, Jong Seung
- Sessler, Jonathan L.
- Arambula, Jonathan F.
- ORCID
- Venue
- Chemical Society Reviews
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2022
- Volume
- 51
- Issue
- 4
- Pages
- 1212-1233
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- PMC
- PMC9398513
- OpenAlex
- W4210763359
- Cited by
- 297
- References
- 75
- Citations by year
- 2026: 65 · 2025: 73 · 2024: 69 · 2023: 69 · 2022: 21
- FWCI
- 7.08
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Chemical Society Reviews (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Research Foundation of Korea (2018R1A3B1052702, 2019M3E5D1A01068998)
- National Cancer Institute (R15 CA232765)
- Welch Foundation (F-0018)
- Topics
- Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- immunogenic cell death, metal-based anticancer agents, platinum complexes, ruthenium complexes, iridium complexes, copper complexes, gold complexes, cancer immunotherapy, interferon-gamma, cytotoxic T lymphocytes, γδ T cells, drug delivery, combination therapy, antitumor immunity
- MeSH terms
- Immunogenic Cell Death, COVID-19, SARS-CoV-2, Antineoplastic Agents, Humans, Immunotherapy, Neoplasms, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.